3D-Micromac (Germany)

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

Ralf C. Bargou, Eugen Leo, Gerhard Zugmaier et al. · Science · 2008 · 1.1K citations

Immunology, Immunoediting, Cancer Patients +18

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

Max S. Topp, Peter Kufer, Nicola Gökbuget et al. · Journal of Clinical Oncology · 2011 · 902 citations · Full text

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers

Philip Went, Mohammad Vasei, Lukas Bubendorf et al. · British Journal of Cancer · 2006 · 380 citations · Full text

Lung Cancers, Cancer Immunosurveillance, Immunology +11

Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody

Torsten Dreier, Grit Lorenczewski, Christian Brandl et al. · International Journal of Cancer · 2002 · 349 citations · Full text

Immunology, Immunologic Mechanism, Cd4 T Cell Responses +19

Serial killing of tumor cells by cytotoxic T cells redirected with a CD19‐/CD3‐bispecific single‐chain antibody construct

Patrick Hoffmann, Robert Hofmeister, Klaus Brischwein et al. · International Journal of Cancer · 2005 · 342 citations · Full text

Cytotoxic T Cells, Immunology, Immunoediting +17